Dynavax Technologies Corporation (NASDAQ:DVAX) — Market Cap & Net Worth

$1.76 Billion USD · Rank #6737

Market Cap & Net Worth: Dynavax Technologies Corporation (DVAX)

Dynavax Technologies Corporation (NASDAQ:DVAX) has a market capitalization of $1.76 Billion ($1.76 Billion) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6737 globally and #1980 in its home market, demonstrating a 0.10% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dynavax Technologies Corporation's stock price $15.50 by its total outstanding shares 113684064 (113.68 Million). Analyse Dynavax Technologies Corporation (DVAX) cash flow conversion to see how efficiently the company converts income to cash.

Dynavax Technologies Corporation Market Cap History: 2015 to 2026

Dynavax Technologies Corporation's market capitalization history from 2015 to 2026. Data shows change from $2.75 Billion to $1.76 Billion (-4.28% CAGR).

Index Memberships

Dynavax Technologies Corporation is a constituent of 4 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.41 Trillion	0.07%	#174 of 976
NASDAQ Composite IXIC	$38.77 Trillion	0.00%	#725 of 3165
NASDAQ Biotechnology NBI	$1.67 Trillion	0.11%	#112 of 263
S&P Small-Cap 600 Index SML	$1.54 Trillion	0.12%	#348 of 602

Weight: Dynavax Technologies Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Dynavax Technologies Corporation Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Dynavax Technologies Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

5.24x

Dynavax Technologies Corporation's market cap is 5.24 times its annual revenue

Industry average: 1.04x Higher than industry average

Latest Price to Earnings (P/E) Ratio

53.16x

Dynavax Technologies Corporation's market cap is 53.16 times its annual earnings

Industry average: 8.30x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2015	$2.75 Billion	$4.05 Million	-$106.79 Million	678.17x	N/A
2016	$449.05 Million	$11.04 Million	-$112.44 Million	40.66x	N/A
2017	$2.13 Billion	$327.00K	-$95.15 Million	6501.20x	N/A
2018	$1.04 Billion	$8.20 Million	-$158.90 Million	126.89x	N/A
2019	$650.27 Million	$35.22 Million	-$152.60 Million	18.46x	N/A
2020	$505.89 Million	$46.55 Million	-$75.24 Million	10.87x	N/A
2021	$1.60 Billion	$439.44 Million	$76.71 Million	3.64x	20.85x
2022	$1.21 Billion	$722.68 Million	$293.16 Million	1.67x	4.13x
2023	$1.59 Billion	$232.28 Million	-$6.39 Million	6.84x	N/A
2024	$1.45 Billion	$277.25 Million	$27.31 Million	5.24x	53.16x

Competitor Companies of DVAX by Market Capitalization

Companies near Dynavax Technologies Corporation in the global market cap rankings as of May 2, 2026.

Key companies related to Dynavax Technologies Corporation by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#499	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#525	Zoetis Inc	NYSE:ZTS	$50.31 Billion	$114.16
#526	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$50.29 Billion	CN¥53.88
#572	GALDERMA GROUP AG	NYSE:GALDY	$45.88 Billion	$42.09

Dynavax Technologies Corporation Historical Marketcap From 2015 to 2026

Between 2015 and today, Dynavax Technologies Corporation's market cap moved from $2.75 Billion to $ 1.76 Billion, with a yearly change of -4.28%.

Year	Market Cap	Change (%)
2026	$1.76 Billion	+0.78%
2025	$1.75 Billion	+20.44%
2024	$1.45 Billion	-8.66%
2023	$1.59 Billion	+31.39%
2022	$1.21 Billion	-24.38%
2021	$1.60 Billion	+216.18%
2020	$505.89 Million	-22.20%
2019	$650.27 Million	-37.49%
2018	$1.04 Billion	-51.07%
2017	$2.13 Billion	+373.42%
2016	$449.05 Million	-83.65%
2015	$2.75 Billion	--

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of Dynavax Technologies Corporation was reported to be:

Source	Market Cap
Yahoo Finance	$1.76 Billion USD
MoneyControl	$1.76 Billion USD
MarketWatch	$1.76 Billion USD
marketcap.company	$1.76 Billion USD
Reuters	$1.76 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Dynavax Technologies Corporation

NASDAQ:DVAX USA Drug Manufacturers - Specialty & Generic

Market Cap

$1.76 Billion

Market Cap Rank

#6737 Global

#1980 in USA

Share Price

$15.50

Change (1 day)

+0.00%

52-Week Range

$9.36 - $15.72

All Time High

$29.70